Finacea (azelaic acid) is a brand-name drug that’s prescribed for rosacea in adults. Finacea comes as a topical gel and topical foam that’s typically applied to the skin twice per day. Finacea belongs ...

As with other drugs, Finacea (azelaic acid) can cause side effects, such as dryness, itching, or burning. If you are not able to tolerate side effects of Finacea, talk with your doctor or pharmacist.

BRIDGEWATER, N.J., April 02, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO) (“Menlo” or the “Company”), a biopharmaceutical company focused on developing and commercializing ...

Foamix, a specialty pharmaceutical company, and LEO Pharma have entered into a settlement and license agreement with an affiliate of Teva to resolve pending patent litigation involving Finacea Foam.

Bayer HealthCare announced the launch of Finacea Foam (azelaic acid) 15% for the topical treatment of the inflammatory papules and pustules of mild to moderate rosacea. Finacea Foam was approved by ...

(RTTNews) - Foamix Pharmaceuticals Ltd. (FOMX) said Tuesday that, together with LEO Pharma, it has settled the Hatch-Waxman litigation with Perrigo, relating to Finacea Foam. Terms of the settlement ...

Berlex Laboratories, an affiliate of Germany's Schering AG , said the U.S. Food and Drug Administration has approved its Finacea Gel for the treatment of inflammatory papules and pustules of mild to ...

Bayer HealthCare announced that the Food and Drug Administration (FDA) has approved Finacea (azelaic acid) Foam 15% for the topical treatment of inflammatory papules and pustules of mild to moderate ...

NEW YORK, July 27 (Reuters) - India's Glenmark Pharmaceuticals' proposed generic version of Bayer AG's Finacea, a gel for treating the common skin condition rosacea, infringes Bayer's patent, a U.S.

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated March 15, 2013 titled "Glenmark confirms patent challenge for its generic version of FINACEA"Source : BSE Advisory Alert: ...